# Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

> **NCT00938418** · PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 43 (estimated)

## Conditions studied

- Stage III Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Dose escalated, accelerated, hypofractionated radiotherapy

## Key facts

- **NCT ID:** NCT00938418
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2009-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938418, "Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00938418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*